Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Nitazoxanide CR by Romark Laboratories LC for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Nitazoxanide CR is under clinical development by Romark Laboratories LC and currently in Phase III for Coronavirus Disease 2019 (COVID-19)....